Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q3 2021 · 10-Q
Revenue$34.17M$34.17M+8.0% vs Q3 2020 Net Income-$4.54M-$4.54Mno prior Q3 2020 on file EPS Diluted-$0.89-$0.89N/M vs Q3 2020 Gross Profit$20,653,000+39.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flowderived$10,943,000−0.6% Free Cash Flowderived$10,696,000+0.8% Margins · derivedGross margin60.4%+13.7 pt vs Q3 2020
Operating margin0.1%+10.3 pt vs Q3 2020
Net margin-13.3%
ended Dec 31, 2020 · filed Feb 3, 2021 · 34 d after period end